AQR Capital Management’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.02M | Buy |
|
|||||
|
2025
Q1 | $930K | Sell |
|
|||||
|
2024
Q4 | $3.87M | Sell |
|
|||||
|
2024
Q3 | $8.79M | Sell |
|
|||||
|
2024
Q2 | $12.9M | Buy |
|
|||||
|
2024
Q1 | $11M | Sell |
|
|||||
|
2023
Q4 | $17.3M | Sell |
|
|||||
|
2023
Q3 | $16.6M | Buy |
|
|||||
|
2023
Q2 | $13.7M | Sell |
|
|||||
|
2023
Q1 | $14.2M | Buy |
|
|||||
|
2022
Q4 | $12.3M | Sell |
|
|||||
|
2022
Q3 | $21.7M | Sell |
|
|||||
|
2022
Q2 | $38.6M | Buy |
|
|||||
|
2022
Q1 | $34.4M | Buy |
|
|||||
|
2021
Q4 | $30.5M | Sell |
|
|||||
|
2021
Q3 | $36.2M | Sell |
|
|||||
|
2021
Q2 | $33.6M | Sell |
|
|||||
|
2021
Q1 | $49.5M | Sell |
|
|||||
|
2020
Q4 | $62.9M | Sell |
|
|||||
|
2020
Q3 | $90.9M | Sell |
|
|||||
|
2020
Q2 | $123M | Sell |
|
|||||
|
2020
Q1 | $171M | Sell |
|
|||||
|
2019
Q4 | $255M | Sell |
|
|||||
|
2019
Q3 | $266M | Sell |
|
|||||
|
2019
Q2 | $318M | Buy |
|
|||||
|
2019
Q1 | $301M | Buy |
|
|||||
|
2018
Q4 | $200M | Buy |
|
|||||
|
2018
Q3 | $218M | Sell |
|
|||||
|
2018
Q2 | $182M | Buy |
|
|||||
|
2018
Q1 | $163M | Buy |
|
|||||
|
2017
Q4 | $167M | Buy |
|
|||||
|
2017
Q3 | $163M | Buy |
|
|||||
|
2017
Q2 | $112M | Buy |
|
|||||
|
2017
Q1 | $99.4M | Sell |
|
|||||
|
2016
Q4 | $85.5M | Sell |
|
|||||
|
2016
Q3 | $96M | Buy |
|
|||||
|
2016
Q2 | $91.5M | Buy |
|
|||||
|
2016
Q1 | $71.7M | Buy |
|
|||||
|
2015
Q4 | $67.3M | Buy |
|
|||||
|
2015
Q3 | $40.2M | Buy |
|
|||||
|
2015
Q2 | $33.6M | Buy |
|
|||||
|
2015
Q1 | $32M | Sell |
|
|||||
|
2014
Q4 | $29.2M | Buy |
|
|||||
|
2014
Q3 | $24.3M | Sell |
|
|||||
|
2014
Q2 | $23M | Buy |
|
|||||
|
2014
Q1 | $18.9M | Buy |
|
|||||
|
2013
Q4 | $15.2M | Buy |
|
|||||
|
2013
Q3 | $12.3M | Sell |
|
|||||
|
2013
Q2 | $17M | Buy |
|